Following a number of corporate and accounting scandals in the USA, Congress passed the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley). Sarbanes-Oxley established new and enhanced standards for corporate accountability in the USA. Although GSK's corporate governance structure was believed to be robust and in line with best practice, certain changes were necessary to ensure compliance with Sarbanes-Oxley.
Sarbanes-Oxley code of ethics
Section 406 of Sarbanes-Oxley, "Code of Ethics for Senior Financial Officers" (the code), requires that GSK has a code of ethics "applicable to its Principal financial officer and comptroller or Principal accounting officer, or persons performing similar functions". There have been no changes in or waivers to the company's code of ethics which require disclosure in accordance with Sarbanes-Oxley.
The code is defined as standards that promote:
GSK formulated a Sarbanes-Oxley code of ethics comprised of seven GSK policies:
Our code of ethics goes beyond the requirements of Sarbanes-Oxley in that it is applicable to all GSK employees. The Chief Executive Officer, Chief Financial Officer, as well as the Senior Vice President, Financial Controller and the Senior Vice President, Finance Services have all signed statements certifying their compliance with the code of ethics.
Document downloads
The following PDFs open in a new window.
To view PDF documents you may need to install Adobe Reader. PDF links on this site open in a new tab.